Cyclopharm defers US guidance despite $17.1M revenue
Cyclopharm (ASX:CYC) defers short-term US installation guidance due to delayed clinical guidelines, despite reporting preliminary global revenue of $17.1 million.
Cyclopharm (ASX:CYC) defers short-term US installation guidance due to delayed clinical guidelines, despite reporting preliminary global revenue of $17.1 million.
Megaport (ASX:MP1) has closed its retail entitlement offer, raising approximately $308 million at $14.30 per share.
Capricorn Metals (ASX:CMM) agreed to divest the Big Springs Gold Project to Sentinel Metals (ASX:SNM) for up to $26 million.
Peter Warren Automotive (ASX:PWR) said vendors of Wakeling Automotive will not extend the deadline for the proposed $28 million acquisition.
Kincora Copper (ASX:KCC) executed share purchase agreements to divest its wholly owned Mongolian subsidiaries for US$10 million.
Black Horse Mining (ASX:BHL) has commenced drilling operations inside the Waste Transfer Facility at its Mount Egerton Gold Project.
KPMG Australia appointed Michael Ebeid as its first independent chair to oversee an executive overhaul.
Osteopore (ASX:OSX) has completed the development project for its intra-operative external ventricular drain guide.
Northern Star Resources (ASX:NST) appointed Suresh Vadnagra as Managing Director and CEO, effective Oct. 5.
Kelsian Group (ASX:KLS) secured a passenger ferry contract in New Zealand valued at an estimated NZ$101 million.
VHM (ASX:VHM) signed a strategic partnership with Iluka Resources (ASX:ILU) involving a $40 million funding package.
Perpetual (ASX:PPT) rejected an unsolicited $1.7 billion takeover bid from private equity vehicle Windflower.